GSK plc (GLAXF) stock
GLAXFOTCPharmaceutical PreparationsAlso trades as GSK
Financials through fiscal 2025, year ended Dec 31, 2025Score 9/30
$24.74+0.30 (+1.21%)
Close on Oct 19, 2026Market cap $106.83BP/E 13.3Yield –
GSK total assets
Total assets on the balance sheet at the end of each period.
GSK's total assets was £61.12B at Dec 31, 2025. For fiscal 2025 it was £61.12B, up 2.8% from the year before. The highest annual figure on record is £80.43B in fiscal 2020.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | £61.12B | +2.8% |
| FY2024 | Dec 31, 2024 | £59.46B | +0.8% |
| FY2023 | Dec 31, 2023 | £59.01B | -1.9% |
| FY2022 | Dec 31, 2022 | £60.15B | -24.0% |
| FY2021 | Dec 31, 2021 | £79.10B | -1.7% |
| FY2020 | Dec 31, 2020 | £80.43B | +0.9% |
| FY2019 | Dec 31, 2019 | £79.69B | +37.2% |
| FY2018 | Dec 31, 2018 | £58.07B | +3.0% |
| FY2017 | Dec 31, 2017 | £56.38B | -4.6% |
| FY2016 | Dec 31, 2016 | £59.08B | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | £61.12B | -22.7% |
| Q4 FY2024 | Dec 31, 2024 | £59.46B | -26.1% |
| Q4 FY2023 | Dec 31, 2023 | £59.01B | -26.0% |
| Q4 FY2022 | Dec 31, 2022 | £60.15B | +3.6% |
| Q4 FY2021 | Dec 31, 2021 | £79.10B | +40.3% |
| Q4 FY2020 | Dec 31, 2020 | £80.43B | +36.1% |
| Q4 FY2019 | Dec 31, 2019 | £79.69B | – |
| Q4 FY2018 | Dec 31, 2018 | £58.07B | – |
| Q4 FY2017 | Dec 31, 2017 | £56.38B | – |
| Q4 FY2016 | Dec 31, 2016 | £59.08B | – |